Buy Call for Divis Laboratories

Sharekhan recommended a buy call on Divi’s Laboratories with a target price of Rs 1800. Let’s take a quick look at the Sharekhan research report on Divi’s Laboratories.
Research Report On Divi’s Laboratories:
The quarterly performance of the stock is quite disappointing. We anticipate the company to a report sales/profit CAGR(Compound Annual Growth Rate) of 21%/18% over FY2019-FY2021.
Outlook:
We retain a buy rating on Divi’s Laboratories with a target price of Rs 1800.
Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.